Several studies show that the transcription factor Forkhead box M1 (FOXM1) is widely expressed in solid tumors [10], acting as a principal promoter of cell-cycle progression, response to DNA damage and drug resistance [11], where its overexpression confers proliferative advantages to cancer cells [12]. Here, FOXM1 is linked to cancer.